Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-23

Clinical Trial Update: Regular Use Tiotropium and Tolerance to Bronchoprotection in Mild Asthma [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing regular tiotropium use and tolerance to bronchoprotection in individuals with mild asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • tiotropium (tiotropium)

Snippet

Sponsor: University of Saskatchewan | Conditions: Asthma | Phase 4 | Status: COMPLETED